Bravecto® Spot-On solution for cats

Bravecto (fluralaner) Spot-On Solution for medium cats, is a spot-on treatment for fleas and ticks, effective for 12 weeks following a single dose.

Bravecto is applied topically using the new 'Twist'n'Use' pipette design, which means the cap doesn't need to be removed.

Instruction :

The content of one full Bravecto pipette is applied to the cat's skin at the base of the cat's skull. The pipette to use is selected based on the cat's weight, after being given its actions last for 12 weeks against fleas and ticks. It kills fleas within 12 hours and ticks within 48 hours.

Treatment should be repeated every three months (12 weeks) for optimal flea and tick control.

Notice on Purchasing Prescription Products and Medications
To ensure the safety and proper use of prescription products and medications, please provide a valid veterinary prescription (issued within the last 6 months) when placing your order.Kindly send the prescription directly via WhatsApp ‪‪+852 9889 5518‬‬ — PETCORE Veterinary Online Pharmacy Prescription Hotline.
We will arrange the dispensing of prescription products and medications in collaboration with PETCORE Veterinary based on the list you provide.However, due to limited stock, some items may be temporarily unavailable.After verifying your prescription, our professional veterinary team will contact you via WhatsApp. Please stay alert for any messages regarding your order and follow-up arrangements.
By placing an order and purchasing any prescription products or medications, you acknowledge that you have read and agreed to the above terms and conditions.

Important Notes
All prescription products and medications are prescribed by registered veterinarians from PETCORE Veterinary Clinic.
These products are for animal treatment use only and must not be resold, distributed, or used for any other purposes.
Packaging may vary depending on the distributor in different regions; however, all products are guaranteed to be genuine and professionally handled by veterinarians.